7Baggers
 Published on: 2025-10-03 06:31:56  newser.com Fri, 03 Oct 2025 11:31:56 GMT
 Dyne Therapeutics' Valuation Leaves No Room For Error (NASDAQ:DYN)  Seeking Alpha Fri, 03 Oct 2025 10:40:00 GMT
 published on: 2025-10-03 00:31:23  newser.com Fri, 03 Oct 2025 05:31:23 GMT
 Dyne Therapeutics appoints Brian Posner to board of directors By Investing.com  Investing.com Nigeria Fri, 03 Oct 2025 03:44:29 GMT
 Dyne Therapeutics Elects Brian Posner to Board  TipRanks Thu, 02 Oct 2025 20:32:11 GMT
 Dyne Therapeutics Appoints Brian Posner to Board of Directors  Quiver Quantitative Thu, 02 Oct 2025 20:14:00 GMT
 Dyne Therapeutics Appoints Brian Posner to its Board of Directors  GlobeNewswire Thu, 02 Oct 2025 20:08:55 GMT
 Tenaya Therapeutics to Participate in Upcoming October Investor Conferences  The Manila Times Thu, 02 Oct 2025 20:07:50 GMT
 Dyne Therapeutics, Inc. Appoints Brian Posner to Its Board of Directors  MarketScreener Thu, 02 Oct 2025 20:05:00 GMT
 Published on: 2025-09-30 03:32:56  newser.com Tue, 30 Sep 2025 08:32:56 GMT
 United States Myotonic Dystrophy Treatment Market Set for Rapid  openPR.com Tue, 30 Sep 2025 06:06:27 GMT
 Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 7.2% - Here's Why  MarketBeat Mon, 29 Sep 2025 22:35:55 GMT
 Dyne Therapeutics (DYN) Gains Orphan Drug Status in Japan for Du  GuruFocus Mon, 29 Sep 2025 13:53:37 GMT
 japan grants orphan drug status to dyne’s dmd treatment by investing.com  Investing.com Australia Mon, 29 Sep 2025 12:57:53 GMT
 Piper Sandler reiterates Overweight rating on Dyne Therapeutics stock  Investing.com Mon, 29 Sep 2025 12:56:38 GMT
 dyne therapeutics (nasdaq:dyn) shares down 3.7% - should you sell?  MarketBeat Wed, 17 Sep 2025 09:07:18 GMT
 dyne therapeutics (nasdaq:dyn) shares down 3.7% - should you sell?  MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
 dyne therapeutics (nasdaq:dyn) trading down 3.7% - here's why  MarketBeat Tue, 16 Sep 2025 06:03:33 GMT
 dyne therapeutics (nasdaq:dyn) ceo sells $35,402.40 in stock  MarketBeat Sun, 14 Sep 2025 00:54:21 GMT
 dyne therapeutics (nasdaq:dyn) shares down 3.7% - what's next?  MarketBeat Sat, 13 Sep 2025 18:17:05 GMT
 dyne therapeutics (nasdaq:dyn) ceo john cox sells 2,640 shares  MarketBeat Thu, 11 Sep 2025 22:13:48 GMT
 invesco ltd. raises holdings in dyne therapeutics, inc. $dyn  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 dyne therapeutics cmo kerr sells shares worth $59k  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 dyne therapeutics executives sell shares for tax obligations  TradingView Mon, 08 Sep 2025 07:00:00 GMT
 dyne therapeutics, inc. $dyn position increased by braidwell lp  MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
 nuveen llc invests $2.34 million in dyne therapeutics, inc. $dyn  MarketBeat Thu, 04 Sep 2025 07:00:00 GMT
 dyne therapeutics, inc. $dyn shares purchased by siren l.l.c.  MarketBeat Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-01 11:40:11  Newser Mon, 01 Sep 2025 16:40:11 GMT
 dyne therapeutics (nasdaq:dyn) upgraded at raymond james financial  MarketBeat Sat, 30 Aug 2025 07:00:00 GMT
 published on: 2025-08-29 13:30:14  Newser Fri, 29 Aug 2025 18:30:14 GMT
 published on: 2025-08-28 13:27:34  Newser Thu, 28 Aug 2025 18:27:34 GMT
 published on: 2025-08-28 12:44:04  Newser Thu, 28 Aug 2025 17:44:04 GMT

Dyne Therapeutics, Inc
(NASDAQ:DYN) 

DYN stock logo

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral ...

Founded: 2017
Full Time Employees: 36
CEO: Joshua T. Brumm  
Sector: Other
Industry: Other

Share this website to your friends